LV10312A - Ciliara neirotropa faktora receptors - Google Patents

Ciliara neirotropa faktora receptors

Info

Publication number
LV10312A
LV10312A LV930978A LV930978A LV10312A LV 10312 A LV10312 A LV 10312A LV 930978 A LV930978 A LV 930978A LV 930978 A LV930978 A LV 930978A LV 10312 A LV10312 A LV 10312A
Authority
LV
Latvia
Prior art keywords
cntf
ciliara
factor receptor
relates
neurotropic factor
Prior art date
Application number
LV930978A
Other languages
English (en)
Other versions
LV10312B (en
Inventor
Samuel Davis
Stephen P Squinto
Mark E Furth
George Yancopoulos
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/676,647 external-priority patent/US5426177A/en
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of LV10312A publication Critical patent/LV10312A/lv
Publication of LV10312B publication Critical patent/LV10312B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
LVP-93-978A 1990-06-01 1993-06-30 The ciliary neurotrophic factor receptor LV10312B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53228590A 1990-06-01 1990-06-01
US07/676,647 US5426177A (en) 1990-06-01 1991-03-28 Ciliary neurotrophic factor receptor
US70067791A 1991-05-15 1991-05-15
PCT/US1991/003896 WO1991019009A1 (en) 1990-06-01 1991-06-03 The ciliary neurotrophic factor receptor

Publications (2)

Publication Number Publication Date
LV10312A true LV10312A (lv) 1994-10-20
LV10312B LV10312B (en) 1995-10-20

Family

ID=27415086

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-978A LV10312B (en) 1990-06-01 1993-06-30 The ciliary neurotrophic factor receptor

Country Status (14)

Country Link
EP (1) EP0533846B1 (lv)
JP (1) JP3266611B2 (lv)
AT (1) ATE195341T1 (lv)
AU (1) AU656732B2 (lv)
CA (1) CA2084075C (lv)
DE (1) DE69132361T2 (lv)
FI (1) FI925457A0 (lv)
HU (2) HUT63464A (lv)
IE (1) IE911867A1 (lv)
IL (1) IL98304A (lv)
LV (1) LV10312B (lv)
NO (1) NO924614L (lv)
PT (1) PT97821A (lv)
WO (1) WO1991019009A1 (lv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169764A (en) * 1990-08-08 1992-12-08 Regeneron Pharmaceuticals, Inc. Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
US5360740A (en) * 1992-07-02 1994-11-01 Regeneron Pharmaceuticals, Inc. Assay system for degenerative muscle disease
US6472178B1 (en) 1998-02-27 2002-10-29 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
WO1994016721A1 (en) * 1993-01-29 1994-08-04 Regeneron Pharmaceuticals, Inc. Methods of treatment using ciliary neurotrophic factor
JP3457321B2 (ja) * 1993-09-09 2003-10-14 リジエネロン・フアーマシユーテイカルズ・インコーポレーテツド Ｃｎｔｆシグナル形質導入経路を用いたアッセイ系
DE4331297A1 (de) * 1993-09-15 1995-03-16 Henkel Kgaa Stückseifen
EP1365785A2 (en) * 2000-05-24 2003-12-03 Regeneron Pharmaceuticals, Inc. Use of ciliary neurotrophic factor
US20200297868A1 (en) * 2016-12-14 2020-09-24 University Of Cincinnati Methods and compositions for the treatment of als
CN113607714B (zh) * 2021-10-08 2022-01-11 成都齐碳科技有限公司 分子膜成膜或表征器件、装置、方法以及生物芯片

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017375A (en) * 1982-11-24 1991-05-21 Baylor College Of Medicine Method to prepare a neurotrophic composition
US4923696A (en) * 1987-05-04 1990-05-08 Baylor College Of Medicine Method to prepare a neurotrophic composition
US5011914A (en) * 1989-01-05 1991-04-30 Collins Franklin D Purified ciliary neurotrophic factor
US4997929A (en) * 1989-01-05 1991-03-05 Synergen, Inc. Purified ciliary neurotrophic factor
IE903130A1 (en) * 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor
CA2038208A1 (en) * 1990-03-14 1991-09-15 Francesco Della Valle Process for the isolation and expression of the human ciliary neuronotrophic factor by recombinant dna technology
IT1247150B (it) * 1991-01-21 1994-12-12 Fidia Spa Processo per la sintesi e la purificazione del fattore neuronotroficociliare umano (cntf) da escherichia coli.

Also Published As

Publication number Publication date
DE69132361D1 (de) 2000-09-14
CA2084075A1 (en) 1991-12-02
WO1991019009A1 (en) 1991-12-12
IE911867A1 (en) 1991-12-04
IL98304A (en) 2008-08-07
ATE195341T1 (de) 2000-08-15
PT97821A (pt) 1992-02-28
CA2084075C (en) 2005-08-16
DE69132361T2 (de) 2001-03-29
JPH06507062A (ja) 1994-08-11
LV10312B (en) 1995-10-20
HUT63464A (en) 1993-08-30
HU9203772D0 (en) 1993-03-29
JP3266611B2 (ja) 2002-03-18
AU8233791A (en) 1991-12-31
NO924614D0 (no) 1992-11-30
HU211976A9 (en) 1996-01-29
IL98304A0 (en) 1992-06-21
EP0533846B1 (en) 2000-08-09
FI925457A (fi) 1992-11-30
AU656732B2 (en) 1995-02-16
FI925457A0 (fi) 1992-11-30
EP0533846A1 (en) 1993-03-31
EP0533846A4 (lv) 1994-04-27
NO924614L (no) 1993-01-21

Similar Documents

Publication Publication Date Title
EP1361229A3 (en) Use of Tyrosine Kinase (PYK2) to produce antibodies
RU98100755A (ru) Соединения нейроактивных стероидов из рядов андростана и прегнана, фармацевтический препарат, содержащий указанное соединение, способ модулирования комплекса рецептор гамка - хлоридный ионофор на животном объекте, способы лечения или профилактики стресса или состояния тревоги, судорожной активности, бессонницы, предменструального синдрома или послеродовой депрессии, нарушений настроения у животного объекта, способ индукции сна и поддержания значительно уровня rem-сна, способ индукции анестезии у животного объекта
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
NO873753D0 (no) Periodisk biologisk luftbehandlingsprosess og system for denne.
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
LV10312A (lv) Ciliara neirotropa faktora receptors
DE69729954D1 (de) Identifizierungsverfahren für Substanzen die an das Pyk2 Polypeptid binden
EP0805206A3 (en) Human cartilage glycoprotein
ES2170056T3 (es) Sistemas de analisis de la actividad de la neurotrofina.
ES2180550T3 (es) Moleculas receptoras de la hormona de glycoproteina.
DE69728897D1 (de) Saeugetierchemokine
DE60120782D1 (de) Bevorzugte segmente des ntp-proteins (neural thread protein) und verfahren zu deren verwendung
ATE273390T1 (de) Säugertier edg-7 rezeptor homologen
Kettman et al. Changes in the protein pattern of murine B cells after mitogenic stimulation
Beckmann Phenylalanine in affective disorders.
PT990000E (pt) Factor 3 de crescimento do tecido conjuntivo
DE69734890D1 (de) Rdgb-proteine
IT8622049A0 (it) Metodo per la determinazione dell'attivita' biologica della proteina c nel plasma umano, e relativi reagenti.
RU95103989A (ru) Способ диагностики острой церебральной ишемии
ITRM950770A0 (it) Metodo per la rivelazione di catecolamine durante il ritmo circadiano,uso di detto metodo per la diagnosi e la terapia di malattie nervose e di stati di stress
Hayashi et al. Ontogeny of glutamic acid decarboxylase, choline acetyltransferase, somatostatin and substance P in monkey cerebellum
Takagi et al. Further analysis with monoclonal antibodies recognizing regional differences in Xenopus optic tectum
DE69832371D1 (de) Varianten des neurotrophischen ziliarischen faktors mit erhöhter rezeptor-selektivität und verfahren zu deren auswahl
Toomaspoeg et al. Influence of ethanol on E-rosette formation by T lymphocytes in alcoholics: Preliminary report
UA15554A (uk) Спосіб прогhозуваhhя ефективhості рефлексотерапії за лазориком